Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Evaluating deceleration and acceleration capacities: Implications for predicting adverse outcomes in patients with
Zhiyao Wei1, Jinghan Huang2, Jie Liu3
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Deceleration capacity (DC) and acceleration capacity (AC) of heart rate predict mortality in hypertrophic cardiomyopathy (HCM) patients. These autonomic markers identify individuals at high risk for adverse outcomes, aiding clinical management.
Area of Science:
- Cardiology
- Autonomic Nervous System Function
- Electrophysiology
Background:
- Abnormal cardiac autonomic function is common in hypertrophic cardiomyopathy (HCM) but its prognostic implications are unclear.
- Deceleration capacity (DC) and acceleration capacity (AC) are emerging markers of parasympathetic and sympathetic activity, respectively.
- Understanding these markers' role in HCM prognosis is crucial for risk stratification.
Purpose of the Study:
- To investigate whether DC and AC can predict adverse clinical outcomes in patients diagnosed with HCM.
- To assess the independent predictive value of DC and AC for mortality in this cohort.
Main Methods:
- A prospective observational cohort study involving 856 unrelated HCM patients.
- Data collected between 2013 and 2022.
- Primary outcome: all-cause death; Secondary outcome: cardiovascular death.
- Cox regression analysis was employed to evaluate associations between variables and outcomes.
Main Results:
- Over a median follow-up of 3.0 years, 25 all-cause deaths and 17 cardiovascular deaths occurred.
- Lower DC values were significantly associated with increased risk of all-cause and cardiovascular death (unadjusted HRs > 1.3, P < .05).
- Adjusted analysis confirmed DC as an independent predictor of all-cause death (aHR = 1.330, P = .010).
- Higher AC values were linked to increased risk for both endpoints (unadjusted HRs > 1.4, P < .001).
- The association between AC and all-cause death remained significant after adjustment (aHR = 1.391, P = .002).
Conclusions:
- Both DC and AC serve as independent predictors of elevated mortality risk in HCM patients.
- These heart rate variability parameters demonstrate clinical utility as electrophysiological markers.
- DC and AC can aid in identifying high-risk individuals with HCM for closer monitoring and management.
Background:
Abnormal cardiac autonomic function is commonly observed in patients with hypertrophic cardiomyopathy (HCM); however, its association with poor prognosis remains unclear. The deceleration capacity (DC) and acceleration capacity (AC) of the heart rate are promising measures reflecting parasympathetic and sympathetic activity of the heart.
Objective:
This study aimed to determine whether DC and AC can predict adverse outcomes in patients with HCM.
Methods:
In this prospective observational cohort study, 856 unrelated patients with HCM were enrolled between 2013 and 2022. The primary outcome was all-cause death, while the secondary outcome was cardiovascular death. Cox regression analysis assessed the associations of variables and clinical outcomes.
Results:
During a median follow-up of 3.0 years (interquartile range: 2.3-3.9), there were 25 cases of all-cause death and 17 cases of cardiovascular death. Lower values of DC showed strong unadjusted associations with the higher risk of all-cause death (hazard ratio [HR] = 1.391 [1.131-1.712], P = .002) and cardiovascular death (HR = 1.311 [1.017-1.689], P = .036). After adjustment, DC remained predictive for all-cause death (adjusted HR = 1.330 [1.072-1.650], P = .010). Consistently, AC predicted higher risk for both end points (all-cause death: HR = 1.458 [1.195-1.779], P < .001; cardiovascular death: HR = 0.404 [1.104-1.789], P = .006), and the association with all-cause death persisted after adjustment (adjusted HR = 1.391 [1.133-1.709], P = .002).
Conclusion:
DC and AC are independent predictors of the high mortality risk in patients with HCM, suggesting their clinical utility as electrophysiological markers for identifying high-risk individuals in this population.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Heart Failure